Breast Cancer Collection
 1-15 of 15 Articles
ACP Journal Club |  15 December 2015
Annual mammography in women 40 to 48 y of age reduced breast cancer mortality at 10 y but not at a median 17.7 y
Melvyn Jones, MBBS, MD, MRCGP
Ann Intern Med. 2015;163(12):JC3. doi:10.7326/ACPJC-2015-163-12-003
ACP Journal Club |  15 September 2015
In postmenopausal women with breast cancer treated with aromatase inhibitors, denosumab reduced fractures
Nicholas Wilcken, MD, PhD; Clara Inkyung Lee, MD
Ann Intern Med. 2015;163(6):JC11. doi:10.7326/ACPJC-2015-163-6-011
ACP Journal Club |  19 May 2015
Tamoxifen for 5 years reduced 16-year risk for breast cancer in women at increased risk
Heather Parsons, MD, MPH; Vered Stearns, MD
Ann Intern Med. 2015;162(10):JC11. doi:10.7326/ACPJC-2015-162-10-011
ACP Journal Club |  20 January 2015
Bisphosphonates do not reduce breast cancer in postmenopausal women
Aju Mathew, MD, MPhil; Adam Brufsky, MD, PhD
Ann Intern Med. 2015;162(2):JC5. doi:10.7326/ACPJC-2015-162-2-005
ACP Journal Club |  20 May 2014
Annual mammography screening did not reduce long-term breast cancer mortality in women 40 to 59 years of age
Suzanne W. Fletcher, MD
Ann Intern Med. 2014;160(10):JC7. doi:10.7326/0003-4819-160-10-201405200-02007
ACP Journal Club |  17 September 2013
Meta-analysis: Selective estrogen-receptor modulators reduce breast cancer incidence
Aman U. Buzdar, MD
Ann Intern Med. 2013;159(6):JC9. doi:10.7326/0003-4819-159-6-201309170-02009
ACP Journal Club |  21 February 2012
Meta-analysis: Adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer
Belinda Kiely, MD; Martin Stockler, MD
Ann Intern Med. 2012;156(6):JC2-4. doi:10.7326/0003-4819-156-6-201202210-02004
ACP Journal Club |  18 October 2011
Exemestane prevented invasive breast cancer in postmenopausal women at moderately increased risk
Laura Rees Willett, MD, FACP
Ann Intern Med. 2011;155(8):JC4-3. doi:10.7326/0003-4819-155-8-201110180-02003
ACP Journal Club |  15 February 2011
Estrogen plus progestin increased long-term risk for invasive breast cancer in postmenopausal women
Robert P. Kauffman, MD
Ann Intern Med. 2011;154(4):JC2-11. doi:10.7326/0003-4819-154-4-201102150-02011
ACP Journal Club |  15 June 2010
Use of paroxetine during tamoxifen therapy for breast cancer was associated with increased breast-cancer and all-cause mortality
Bruce E. Hillner, MD
Ann Intern Med. 2010;152(12):JC6-13. doi:10.7326/0003-4819-152-12-201006150-02013
ACP Journal Club |  16 March 2010
Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes
Joy Melnikow, MD, MPH
Ann Intern Med. 2010;152(6):JC3-4. doi:10.7326/0003-4819-152-6-201003160-02004
ACP Journal Club |  16 February 2010
Review: In women 39 to 69 years of age, screening with mammography reduces breast cancer mortality
Laura Rees Willett, MD, FACP
Ann Intern Med. 2010;152(4):JC2-7. doi:10.7326/0003-4819-152-4-201002160-02007
ACP Journal Club |  16 June 2009
Risk for breast cancer declined after postmenopausal hormone therapy was stopped
Bruce E. Hillner, MD
Ann Intern Med. 2009;150(12):JC6-11. doi:10.7326/0003-4819-150-12-200906160-02011
ACP Journal Club |  18 November 2008
Tibolone reduced risk for fractures and breast cancer but increased risk for stroke in older women with osteoporosis
Robert P. Kauffman, MD
Ann Intern Med. 2008;149(10):JC5-8. doi:10.7326/0003-4819-149-10-200811180-02008
ACP Journal Club |  18 November 2008
4% lidocaine gel applied to the breasts before screening mammography reduced discomfort
Chris Del Mar, MD
Ann Intern Med. 2008;149(10):JC5-9. doi:10.7326/0003-4819-149-10-200811180-02009
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.